TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 11:48 am Purchase | 2022-07-01 | 13G | Ovid Therapeutics Inc. OVID | TAKEDA PHARMACEUTICAL CO LTD | 8,781,996 12.200% | 7,000,000 (+392.82%) | Filing |